title: [Simvastatin 40 mg as secondary prophylaxis: Effective, tolerable and cost-efficient!].
authors.affiliation: Läkemedelskommittén Halland. Anders.Hernborg@telia.com
authors.forename: Anders
authors.initials: A
authors.lastname: Hernborg
authors.forename: Paul
authors.initials: P
authors.lastname: Hjemdahl
authors.forename: Jan
authors.initials: J
authors.lastname: Håkansson
mesh_terms: D000924:Anticholesteremic Agents / Q000008:administration & dosage* / Q000191:economics; D008078:Cholesterol, LDL / Q000097:blood; D003327:Coronary Disease / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D017048:Health Care Costs; D006801:Humans; D012307:Risk Factors; D019821:Simvastatin / Q000008:administration & dosage* / Q000191:economics
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D019821:Simvastatin